The Food & Drug Administration (FDA) has approved the use of the insulin spray Oral-lyn for some patients with serious forms of Type 1 or Type 2 diabetes that are not eligible for the current Phase III of the drug’s clinical trial, according to a recent report from the Associated Press.
The spray, made by the biotech company Generex, was approved under the FDA’s Investigative New Drug program.
To receive free news updates from Diabetes News Hound delivered straight to your Inbox, sign up here. If you already receive the free Alerts, spread the word by telling a friend to sign up here.
